Today has been an active day in the stock market. In case you missed it, here are the biggest stories of the day so far:
The Veritas Farms (OTCMKTS: VFRM) opportunity is growing. Not only is the company executing on big-box placements, it is expanding production abilities in a big way! Read the full story here.
Genprex (NASDAQ: GNPX) is becoming a very serious opportunity, with a leader that has a personal vendetta against cancer. Learn more here!
Seelos Therapeutics (NASDAQ: SEEL) is having a strong day in the market after acquiring a new gene therapy asset with tremendous potential. Check out the story!
Cemtrex (NASDAQ: CETX) is climbing after announcing serious growth in its contractual backlog. Here’s the scoop!
Atossa Genetics (NASDAQ: ATOS) announced positive clinical data, setting the stage for a pivotal trial and a potential entrance into a large market. Here’s what you need to know!
Finally, Dova Pharmaceuticals (NASDAQ: DOVA) announced a regulatory approval in Europe, opening the door to a serious market opportunity! Here’s the story!
CNA Finance, parent company to Alpha Stock News, has been paid to cover Genprex news.
